Kaken Pharmaceutical Co., Ltd. produces, markets, and sells medical products, medical devices, and agrochemicals in Japan and internationally. It offers pharmaceutical products and medical devices, such as Clenafin, a topical treatment for onychomycosis; Artz, an anti-osteoarthritis agent; Seprafilm, a semitransparent film-type absorbable adhesion barrier, which is applied to damaged tissue; Fiblast, a spray-on drug for the treatment of pressure ulcers and other skin ulcers; Regroth, a medicinal product for periodontal regeneration; and Hernicore for the treatment of lumbar disc herniation. The company also provides Adofeed, a pain- and inflammation-relieving plaster; Ebrantil for the treatment of dysuria and hypertension; Procylin, an oral-use prostaglandin I2 analog; Lipidil, an anti-hyperlipidemia agent; Mentax, an anti-trichophyton agent; and Loxoprofen Na Tape, a pain-relieving and anti-inflammatory plaster. In addition, it offers Ropion, a pain relief injection; and agrochemicals and animal health products, including Polyoxins that is used as fungicide; Pentoxazone, a rice herbicide; and Salinomycin, an anti-coccidial feed additive for chicken. Further, the company is developing BBI-4000 that has completed phase III clinical trial for primary axillary hyperhidrosis; KMW-1, which is in phase III clinical trial for the removal of eschar with thermal burns; KAR for treatment of hide lice infestation; and KP-607, which is in phase II clinical trial for the treatment of onychomycosis. Additionally, it is involved in the rental of Bunkyo Green Court, a commercial complex. The company offers its products under the Mentax Lotrimin Ultra, Mentax Butena, Mentax, Kaifen, Fiblast, and Jublia brands. It has license agreements with Corbus Pharmaceuticals Holdings, Inc. and Arbor Pharmaceuticals, LLC. Kaken Pharmaceutical Co., Ltd. was founded in 1917 and is headquartered in Tokyo, Japan.
Kaken Pharmaceutical Dividend Announcement
• Kaken Pharmaceutical announced a semi annually dividend of ¥75.00 per ordinary share which will be made payable on 2025-06-01. Ex dividend date: 2025-03-28
• Kaken Pharmaceutical's trailing twelve-month (TTM) dividend yield is 2.74%
Kaken Pharmaceutical Dividend History
| Ex-Div date | Dividend amount | Dividend type | Pay date |
|---|---|---|---|
| 2025-03-28 | ¥75.00 | semi annually | 2025-06-01 |
| 2024-09-27 | ¥40.00 | semi annually | 2024-11-29 |
| 2024-03-28 | ¥75.00 | semi annually | |
| 2023-09-28 | ¥75.00 | semi annually | 2023-11-30 |
| 2023-03-30 | ¥75.00 | semi annually | 2023-06-30 |
| 2022-09-29 | ¥75.00 | semi annually | 2022-11-30 |
| 2022-03-30 | ¥75.00 | semi annually | 2022-06-30 |
| 2021-09-29 | ¥75.00 | semi annually | 2021-11-30 |
| 2021-03-30 | ¥75.00 | semi annually | 2021-06-30 |
| 2020-09-29 | ¥75.00 | semi annually | 2020-11-30 |
| 2020-03-30 | ¥75.00 | semi annually | 2020-06-29 |
| 2019-09-27 | ¥75.00 | semi annually | 2019-11-29 |
| 2019-03-27 | ¥75.00 | semi annually | 2019-06-28 |
| 2018-09-26 | ¥75.00 | semi annually | 2018-11-30 |
| 2018-03-28 | ¥75.00 | semi annually | 2018-06-29 |
| 2017-09-27 | ¥75.00 | semi annually | 2017-11-30 |
| 2017-03-29 | ¥75.00 | semi annually | 2017-06-30 |
| 2016-09-28 | ¥75.00 | semi annually | |
| 2016-03-29 | ¥10.00 | semi annually | |
| 2015-09-28 | ¥34.00 | semi annually | |
| 2015-03-27 | ¥32.00 | semi annually | |
| 2014-09-26 | ¥27.00 | semi annually | |
| 2014-03-27 | ¥24.00 | semi annually |
Kaken Pharmaceutical Dividend per year
Kaken Pharmaceutical Dividend growth
Kaken Pharmaceutical Dividend Yield
Kaken Pharmaceutical current trailing twelve-month (TTM) dividend yield is 2.74%. Interested in purchasing Kaken Pharmaceutical stock? Use our calculator to estimate your expected dividend yield:
Kaken Pharmaceutical Financial Ratios
P/E ratio21.87
PEG ratio-4.30
P/B ratio1.12
ROE5.13%
Payout ratio0.00%
Current ratio4.72
Quick ratio3.98
Cash Ratio2.25
Kaken Pharmaceutical Dividend FAQ
How much is the next Kaken Pharmaceutical dividend?
Kaken Pharmaceutical's board of directors will review the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the next Kaken Pharmaceutical dividend. The next Kaken Pharmaceutical dividend will be released in March, or September.
When is Kaken Pharmaceutical dividend paid?
Kaken Pharmaceutical pays dividends on a semi annually basis. The specific dates may vary each year but are generally around March, and September. However, please note that the exact timing and amount can vary, and companies may also decide to change their dividend policy based on their financial health and other considerations.
What dividend does Kaken Pharmaceutical pay?
The specific amount of Kaken Pharmaceutical dividend can vary from quarter to quarter and year to year, based on a variety of factors including the company's financial performance, the global economic situation, and the decisions of its board of directors. In the above table you can find Kaken Pharmaceutical's dividend history.
Does Kaken Pharmaceutical stock pay dividends?
Yes, Kaken Pharmaceutical does pay dividends to its shareholders. However, the specific amount and frequency of these dividends can vary based on a variety of factors, including the company's financial performance, the global economic situation, and the decisions of its board of directors. In the above table you can find Kaken Pharmaceutical's dividend history.
How much dividend does Kaken Pharmaceutical pay?
Kaken Pharmaceutical paid ¥115.0 in 2024, ¥150.0 in 2023, ¥150.0 in 2022, ¥150.0 in 2021, and ¥150.0 in 2020.
How often does Kaken Pharmaceutical pay dividends?
Kaken Pharmaceutical typically pays dividends on a semi annually basis. This means that dividends are usually distributed 2 times a year. The specific payout dates may vary each year but generally fall around March, and September.
What is Kaken Pharmaceutical's dividend yield?
The current dividend yield for Kaken Pharmaceutical is 2.74%. The dividend yield is calculated by dividing the annual dividend payment by the price of the stock. Both of these numbers can fluctuate daily due to changes in the stock price and any updates to the dividend payment. Use the dividend calculator on this page to calculate Kaken Pharmaceutical's exact dividend yield.
When does Kaken Pharmaceutical go ex dividend?
Kaken Pharmaceutical's ex-dividend date for the latest dividend was on 2025-03-28. Kaken Pharmaceutical typically goes ex-dividend a few weeks before the payment date. The specific dates can vary each year and for each dividend payment.
When is the next Kaken Pharmaceutical dividend paid?
Kaken Pharmaceutical pays dividends on a semi annually basis, typically around March, or September, but the exact dates can vary each year.
Will Kaken Pharmaceutical increase its dividend?
Decisions about dividend payments are made by the company's board of directors and are based on a variety of factors. To understand whether Kaken Pharmaceutical will increase its dividend, it's beneficial to look at the company's earnings, financial health, future business prospects, and the overall economic environment.
How much is Kaken Pharmaceutical dividend per share?
Kaken Pharmaceutical paid ¥115.0 per share in 2024 and ¥150.0 per share in 2023. The amount of dividend per share that Kaken Pharmaceutical pays can vary each quarter based on a range of factors including the company's earnings, financial health, and decisions made by its board of directors.
Is Kaken Pharmaceutical a dividend aristocrat?
No, the term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Kaken Pharmaceutical a dividend king?
No, a "Dividend King" is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Kaken Pharmaceutical a dividend stock?
Yes, Kaken Pharmaceutical is considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
Is Kaken Pharmaceutical a good dividend stock?
Whether Kaken Pharmaceutical is a good dividend stock depends on several factors and can vary depending on individual investment goals, risk tolerance, and the overall market conditions. Kaken Pharmaceutical has a history of paying regular dividends, which can make it attractive to income-focused investors.
Other factors to consider when evaluating Kaken Pharmaceutical as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Other factors to consider when evaluating Kaken Pharmaceutical as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Does Kaken Pharmaceutical pay dividends monthly?
Kaken Pharmaceutical typically pays dividends on a semi annually basis.
Does Kaken Pharmaceutical pay dividends quarterly?
Kaken Pharmaceutical currently pays dividends on a semi annually basis.
Has Kaken Pharmaceutical ever paid a dividend?
Yes, Kaken Pharmaceutical has a history of paying dividends to its shareholders. Kaken Pharmaceutical is known for its dividend payments, which have made it an attractive investment for income-focused investors.
How to buy Kaken Pharmaceutical dividend stocks?
To buy Kaken Pharmaceutical you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees, account minimums, and the availability of dividend reinvestment programs (DRIPs) if you wish to reinvest your dividends automatically.
Place an order: Use the brokerage's trading platform to place an order to buy Kaken Pharmaceutical stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
Place an order: Use the brokerage's trading platform to place an order to buy Kaken Pharmaceutical stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
When does Kaken Pharmaceutical pay dividends 2024?
Kaken Pharmaceutical pays dividends on a semi annually basis. 2024 dividend payments are in 2025-06-01. However, please note that the exact timing and amount can vary, and companies may also decide to change their dividend policy based on their financial health and other considerations.
Will Kaken Pharmaceutical increase its dividend in 2024?
Decisions regarding Kaken Pharmaceutical dividend increases are typically made by a company's board of directors based on various factors, including financial performance, cash flow, investment needs, and market conditions. For an up-to-date Kaken Pharmaceutical dividend overview you can look into the above table of dividend history.
How Kaken Pharmaceutical dividend works?
The Kaken Pharmaceutical dividend works by distributing a portion of the company's profits to its shareholders on a per-share basis. Here's a general overview of how Kaken Pharmaceutical's dividend process works:
1. Determination of Dividend: Kaken Pharmaceutical's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, Kaken Pharmaceutical publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, Kaken Pharmaceutical distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from Kaken Pharmaceutical are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
1. Determination of Dividend: Kaken Pharmaceutical's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, Kaken Pharmaceutical publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, Kaken Pharmaceutical distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from Kaken Pharmaceutical are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
How are Kaken Pharmaceutical dividends paid?
Kaken Pharmaceutical dividends are typically paid in cash directly to eligible shareholders. The payment process involves the following steps:
1. Record Date: Kaken Pharmaceutical sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, Kaken Pharmaceutical distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: Kaken Pharmaceutical declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
1. Record Date: Kaken Pharmaceutical sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, Kaken Pharmaceutical distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: Kaken Pharmaceutical declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
How many times does Kaken Pharmaceutical pay dividends?
Kaken Pharmaceutical typically pays dividends on a semi annually basis. The specific payment dates can vary each year and are usually announced when the company releases its financial results for each quarter.
What months does Kaken Pharmaceutical pay dividends?
The general pattern is that Kaken Pharmaceutical pays dividends around March, and September. However, the exact payment dates can vary each year and are typically announced when the company releases its financial results for each quarter.
Is Kaken Pharmaceutical dividend safe?
The safety of Kaken Pharmaceutical's dividend is subject to various factors and cannot be determined with certainty. It is influenced by the company's financial performance, cash flow, and the overall economic and industry conditions.
To assess the safety of Kaken Pharmaceutical's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review Kaken Pharmaceutical's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.
To assess the safety of Kaken Pharmaceutical's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review Kaken Pharmaceutical's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.